Long term outcome of patients with mantle cell lymphoma following autologous stem cell transplantation.

被引：0
|
作者：
Jacobsen, ED [1 ]
Neuberg, D [1 ]
Fisher, DC [1 ]
Nadler, LM [1 ]
Soiffer, RJ [1 ]
Freedman, AS [1 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：600S / 600S
页数：1
相关论文
共 50 条
  • [31] Prognosis and outcome of stem cell transplantation for mantle cell lymphoma
    Cheminant, Morgane
    Robinson, Stephen
    Ribrag, Vincent
    Le Gouill, Steven
    Suarez, Felipe
    Delarue, Richard
    Hermine, Olivier
    EXPERT REVIEW OF HEMATOLOGY, 2015, 8 (04) : 493 - 504
  • [32] Autologous stem cell transplantation and rituximab for mantle cell lymphoma.
    Capote, FJ
    González-Barca, E
    Bergua, JM
    Pascual, MJ
    García-Boyero, R
    Ribera, JM
    Jiménez, A
    Romero, A
    Giraldo, P
    Fernández-Calvo, J
    Ramírez, J
    Amigo, ML
    Muñoz, MI
    Caballero, D
    Guinot, M
    Oriol, A
    Queizán, JA
    Cantalapiedra, A
    Moraleda, JM
    Grande, C
    Palomera, L
    Almagro, M
    Leon, A
    Fernández-Sevilla, A
    Gil, JL
    BLOOD, 2005, 106 (11) : 592A - 592A
  • [33] Double autologous stem cell transplantation in mantle cell lymphoma.
    Bolaman, Z
    Kadikoylu, G
    Barutca, S
    Senturk, T
    BLOOD, 2001, 98 (11) : 390B - 390B
  • [34] Autologous Stem Cell Transplantation (ASCT) in Mantle Cell Lymphoma (MCL)
    Oinonen, R
    Jantunen, E
    Itälä, M
    Lehtinen, T
    Kuittinen, O
    Franssila, K
    Wiklund, T
    Elonen, E
    BONE MARROW TRANSPLANTATION, 2001, 27 : S258 - S258
  • [35] Autologous stem cell transplantation (ASCT) for mantle cell lymphoma (MCL).
    Conde, E
    Marco, F
    Caballero, D
    Arranz, R
    Lahuerta, JJ
    Sureda, A
    Bermudez, A
    Bosch, F
    García-Conde, J
    Marín, J
    Gandarillas, M
    Insunza, A
    León, A
    Zuazu, J
    Petit, J
    García-Laraña, J
    Gonzalez-Ponte, L
    Carrera, D
    Rubio-Félix, D
    Grande, C
    Gutierrez, M
    Varela, MR
    Pérez-Equiza, C
    Rifón, J
    Bello, JL
    Albo, C
    Ruiz, JCG
    Besalduch, J
    San Miguel, J
    Fernández-Rañada, JM
    Sierra, J
    Zubizarreta, A
    BLOOD, 2002, 100 (11) : 643A - 643A
  • [36] Long-term outcome of Hodgkin's disease patients following high dose busulfan, etoposide, cyclophosphamide and autologous stem cell transplantation.
    Farag, S
    Bolwell, B
    Elder, P
    Penza, S
    Kalaycio, M
    Avalos, B
    Pohlman, B
    Marcucci, G
    Molina, A
    Sobecks, R
    Lin, T
    Andresen, S
    Copelan, E
    BLOOD, 2002, 100 (11) : 863A - 863A
  • [37] Primary treatment with autologous stem cell transplantation in mantle cell lymphoma:: outcome related to remission pretransplant
    Andersen, NS
    Pedersen, L
    Elonen, E
    Johnson, A
    Kolstad, A
    Franssila, K
    Langholm, R
    Ralfkiær, E
    Åkerman, M
    Eriksson, M
    Kuittinen, O
    Geisler, CH
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2003, 71 (02) : 73 - 80
  • [38] Improved long-term outcome in patients with CML following non-nyeloablative stem cell transplantation.
    Slavin, S
    Shapira, MY
    Amar, A
    Ackerstein, A
    Samuel, S
    Aker, M
    Naparstek, E
    Nagler, A
    Or, R
    BLOOD, 2002, 100 (11) : 456B - 456B
  • [39] Pseudomembranous colitis following autologous stem cell transplantation.
    Hickey, JM
    Tompkins, KA
    Duggan, PR
    BLOOD, 2004, 104 (11) : 351B - 351B
  • [40] Late effects in patients with mantle cell lymphoma treated with or without autologous stem cell transplantation
    Ekberg, Sara
    Smedby, Karin E.
    Albertsson-Lindblad, Alexandra
    Jerkeman, Mats
    Weibull, Caroline E.
    Glimelius, Ingrid
    BLOOD ADVANCES, 2023, 7 (05) : 866 - 874
12345